Regulator
The FDA cleared a Medtronic vessel-sealing instrument for use with Hugo. Medtronic expects Hugo to pass 50,000 completed operations this financial year.
A regulator's decision · Sets Hugo's stage
What the source says
“With the robot now available in the U.S., Medtronic expects Hugo to pass 50,000 completed procedures this financial year”
What it means
Hugo, from Medtronic, is at stage 5 of 5 on our ladder: regulator-cleared or mass market. This event is one of the milestones that placed it there.
Human help: The maker hasn't said whether people help it remotely.
More on Hugo
- Medtronic agreed to sell Cornerstone Robotics' Sentire surgical robot alongside Hugo in some markets outside the US, as part of a deal of about $700 million.
- Medtronic asked the FDA to clear Hugo for general surgery, including hernia repair, and for gynecologic surgery.
- The first US operation with Hugo, a prostate removal, was done at Cleveland Clinic in February 2026.
- The FDA cleared Hugo for soft-tissue urology operations, such as on the prostate, kidney and bladder.
- Medtronic executives said supply chain and manufacturing problems slowed Hugo's rollout after the pandemic.
- Hugo received the CE mark, which allows it to be sold in Europe.